Renue Blue Skincare
Sister brand to Renue by Science - nanoliposome delivery technology applied to topical skin longevity.
Renue by Science's sister brand - same nanoliposome delivery science the parent company applies to internal NMN, now applied to topical skin longevity.
Renue Blue launched in 2024 as the skincare-vertical extension of Renue by Science's nanoliposome platform. The thesis: if encapsulation technology meaningfully improves bioavailability for oral and transdermal NMN, the same delivery science should improve absorption of topical longevity actives - liposomal NAD+, NMN, NR, methylene blue, glutathione, and alpha-lipoic acid - into the dermal layer where they need to act. This is an NAD+/NMN/NR topical line, not a conventional peptide-and-growth-factor serum.
The brand sits in the "skincare-as-longevity" segment alongside AV Laboratories (luxury longevity skincare), Aramore Skincare, and TIMEBEAM. The differentiator is the cross-pollination from the parent company - Renue Blue formulations explicitly leverage the nanoliposome IP that powers Renue by Science's liposomal NMN line, giving it a more rigorous biotech provenance than most "clean beauty" longevity-positioned brands.
For longevity buyers, Renue Blue fits when the goal is topical skin science as part of a broader longevity stack - paired with foundational supplements (Thorne, Momentous), an NMN/NAD bet (Wonderfeel or Renue by Science's internal line), and a structured topical routine. It's not the brand for buyers who want a 12-step Korean skincare regimen or who default to dermatologist-prescribed actives like tretinoin.
Longevity-stack buyers who want a topical skincare layer with biotech delivery-science provenance, particularly those already running Renue by Science internal NMN.
You want dermatologist-grade actives (tretinoin, hydroquinone) - those require prescription channels. Or you're cost-anchored to drugstore skincare ($15-30) and don't value the nanoliposome delivery angle.
Specifications
Most often compared with
Featured in these curated stacks
We’ve included this product in 1 editorial bundle - groupings of 4-7 items that work as a system.
Where this fits
Renue Blue Nanoliposome Skin Longevity Stack cross-shops across several editorial surfaces - the full brand catalog, the buyer-intent tags this item carries, the price band it qualifies for, and any execution playbook that uses it.
Renue Blue Nanoliposome Skin Longevity Stack - buyer FAQ
Renue Blue vs Exoceuticals - which skincare?
Different molecular tier. Renue Blue uses nanoliposome encapsulation for NAD+ pathway actives - liposomal NAD+, NMN, NR, methylene blue, glutathione, and ALA - not peptides or growth factors. Exoceuticals uses exosome biotech (cell-signaling vesicles). Both are mechanism-of-action skincare beyond standard retinoids/peptides. For buyers wanting Renue's platform expertise applied to topical NAD+, Renue Blue. For exosome-specific bets, Exoceuticals.
Is nanoliposome delivery actually different from regular liposomal?
Smaller particle size (~100nm vs ~250nm) - in theory penetrates deeper into the dermis. The bioavailability lift vs standard liposomal topicals is debated in published research. Renue's platform expertise (they've been doing liposomal delivery on the supplement side since 2018) is the actual brand differentiator vs newer skincare-only entrants.
Stack with my existing retinoid?
Yes - Renue Blue's actives (NAD+, NMN, NR, methylene blue, glutathione, ALA) target different pathways than retinoids. Best practice is alternate-night layering (retinoid one night, Renue Blue the next) to avoid barrier disruption. Both can cause mild irritation when stacked simultaneously. Patch test before committing.